TP53 and colorectal carcinoma: DEK is an inhibitor of p53-dependent and -independent cellular senescence and apoptotic phenotypes [7], [14], [16], and transcriptionally upregulated by the Rb/E2F pathway, which is frequently perturbed in CRC [17]–[19].